Search
This report summarises the epidemiology of hospitalisations with laboratory-confirmed influenza during the 2017 influenza season
Here, the role, status, and directions in Group A Streptococcus vaccines research are discussed
Naturally acquired anti-HPV-16 antibodies were associated with a decreased risk of subsequent infection and cervical abnormalities in women >25 years
This study provides a quantitative estimate of the total burden of invasive pneumococcal disease preventable by vaccination programs in Australia
The aim of this study was to describe the characteristics of patients with multidrug-resistant tuberculosis and to investigate risk factors
This study will assess the effect of adjunctive clindamycin on patient-centred outcomes in severe, toxin-mediated S. aureus infections
Large variation in antibiotic prescribing amongst clinicians is demonstrated and increased, corresponding with escalating case complexity and persisting MRSA bacteraemia
One dose of MenACWY-TT boosts protection against MenC in primed children, is safe and extends protection against MenA, MenW and MenY
We identified the existence of more than 290 clinically associated genomic phylogroups across 22 countries, highlighting challenges in designing vaccines of global utility
Overall, the 2016 influenza vaccine showed good protection against laboratory-confirmed infection among general practice patients